
BioLife Solutions (BLFS) Stock Forecast & Price Target
BioLife Solutions (BLFS) Analyst Ratings
Bulls say
BioLife Solutions is set to experience continued growth, with a projected revenue of $95.8M for FY2025 and $112.6M for FY2026, representing 27-29% YoY growth. The company's strong position in the market is supported by its Cell Processing platform's revenue of $93.0-94.0M. However, risks such as slower growth, inability to acquire new customers, sales fluctuations in emerging markets, and potential dilution risk should be monitored closely. Based on a comparable universe analysis, our 12-month price target for BioLife Solutions is $32 per share.
Bears say
BioLife Solutions is facing increasing competition in the CGT industry, with larger companies such as Thermo Fisher Scientific and Catalent entering the market. In addition, the company's reliance on a single product, CryoStor, leaves it vulnerable to changes in the market and potential disruptions. The company's negative earnings and low profit margins also raise concerns about its long-term sustainability and ability to generate significant returns for investors.
This aggregate rating is based on analysts' research of BioLife Solutions and is not a guaranteed prediction by Public.com or investment advice.
BioLife Solutions (BLFS) Analyst Forecast & Price Prediction
Start investing in BioLife Solutions (BLFS)
Order type
Buy in
Order amount
Est. shares
0 shares